HARRIS KAPLAN, CEO
Harris has led Healogix from its start in 2004, overseeing its emergence as one of the premier market research and consultancies serving the pharmaceutical industry. He brings a wealth of experience having been involved in the development and launch of over 75 new Rx products including blockbusters Crestor, Rituxan, Nexium, Lipitor, Norvasc, Viagra and Herceptin. His unique perspective and enviable track record enables Harris to quickly gain the respect and trust of executives at leading pharmaceutical companies around the world.
Harris co-founded Migliara-Kaplan Associates which grew steadily under his leadership to become the world’s largest custom marketing research company, serving 19 of the top 20 pharmaceutical companies. Migliara-Kaplan Associates specialized in helping companies identify new product opportunities. Migliara-Kaplan was acquired by NFO in 1996 and is now part of TNS Healthcare.
Harris was also cofounder of Cozint Interactive which was acquired by GFK, the German based research company. Harris serves as an advisor to several venture capital funds and is on the Board of Directors of Informed Medical Communications, Informedix, and the Kernan Orthopedic Hospital.